Streetbeat News

Earnings

EGOX

IVVD

SINT

SLRX

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) shares surged 31.4% in pre-market trading following a narrower Q4 net loss compared to the previous year. Other stocks also showed significant movement in pre-market trading, with notable gainers including Next.e.GO N.V. (NASDAQ:EGOX) and MicroAlgo Inc. (NASDAQ:MLGO), and losers such as Sintx Technologies, Inc. (NASDAQ:SINT) and Invivyd, Inc. (NASDAQ:IVVD).

Portfolio Pulse from Avi Kapoor

March 25, 2024 | 12:03 pm

SONO

Recent analyst ratings for Sonos (NASDAQ:SONO) show a positive trend, with 4 analysts offering views ranging from bullish to somewhat bullish over the past three months. The average 12-month price target has been raised to $24.25, indicating a 21.25% increase from the previous target of $20.00. Key financial indicators reveal Sonos's strong market performance, including a notable net margin of 13.21% and an ROE of 14.54%, despite a revenue decline of -8.88% over the last quarter.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 12:02 pm

XIACF

Xiaomi (OTC:XIACF) announced its first electric vehicle, the SU7 sedan, will be priced below $70,000. The vehicle, with two versions offering up to 800km range, surpasses Tesla's Model S in range. Official pricing will be revealed on March 28, with orders starting subsequently. Xiaomi aims to enter the top five automakers, with the CEO comparing the SU7 to Porsche Taycan and Tesla Model S. Despite new initiatives expenses, Xiaomi reported a 126.3% year-on-year profit growth for 2023.

Portfolio Pulse from Anan Ashraf

March 25, 2024 | 12:01 pm

Ivanhoe Electric (IE) has completed an earn-in to acquire a 60% interest in the Samapleu-Grata Nickel-Copper project in the Ivory Coast. The project, in partnership with Sama Resources, has a new preliminary economic assessment showing a pre-tax NPV8 of $463M and a pre-tax IRR of 28.2%, with an estimated initial capital cost of $338M. It is expected to have a 16-year mine life, producing copper and nickel concentrates along with platinum, palladium, and cobalt by-products.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:49 am

AEHR

Aehr reported preliminary Q3 revenue of $7.6M, significantly below the $14.32M estimate, and an adjusted EPS loss of $(0.03)-$(0.04), contrary to the expected $0.13. For FY24, Aehr anticipates revenue of $65M, below the $77.41M estimate, with an adjusted EPS of $0.48 versus the expected $0.77. The company also expects a GAAP net loss for Q3 but projects a GAAP net income for the full fiscal year.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:46 am

SLRX

Salarius Pharmaceuticals' shares surged following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:45 am

AMD

INTC

MASI

QQQ

SPY

TSLA

UAL

Wall Street is expected to open lower, influenced by concerns over China's plan to exclude U.S. chipmakers from government PCs and servers, and anticipation of Federal Reserve speeches. Last week, the market saw a recovery after the Fed hinted at possible rate cuts, but ended with slight retreats. Analysts offer mixed views, with some predicting a correction and others remaining bullish. Premarket trading saw declines in major ETFs and companies like AMD, INTC, and TSLA, while MASI surged on news of an upcoming proxy battle.

Portfolio Pulse from Shanthi Rexaline

March 25, 2024 | 11:40 am

ATXS

Astria Therapeutics, Inc. (NASDAQ:ATXS) announced positive initial results from the ALPHA-STAR Phase 1b/2 trial for STAR-0215 in treating hereditary angioedema (HAE). The results showed a significant reduction in monthly attack rates and a favorable safety profile, supporting advancement to Phase 3 development with trials starting in Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:40 am

PRGS

Progress Software Corporation (NASDAQ:PRGS) is anticipated to report lower earnings for Q1 on March 26, 2024, with an expected EPS of $1.14, down from $1.19 year-over-year. Revenue is projected at $181.91 million. The company recently priced a $400 million convertible senior notes offering. Shares dropped 0.8% to $52.48. Analysts from Wedbush, Oppenheimer, Citigroup, Guggenheim, and JP Morgan have provided ratings and price targets, with the most recent being a price target increase from Wedbush to $67.

Portfolio Pulse from Avi Kapoor

March 25, 2024 | 11:38 am

FTHM

HHH

Howard Hughes Holdings Inc. (HHH) and Fathom Holdings Inc. (FTHM) are highlighted as the top 2 oversold real estate stocks, potentially undervalued. HHH reported better-than-expected Q4 earnings, while FTHM posted downbeat quarterly results. Both stocks have an RSI below 30, indicating they may be oversold and could see a price rebound.

Portfolio Pulse from Avi Kapoor

March 25, 2024 | 11:37 am